DMG-PEG-Mal 1000
Full Name: 1,2-Dimyristoyl-rac-glycerol-3-methoxypolyethylene glycol 1000 maleimide
Abbreviation: DMG-PEG1000-Maleimide, DMG-PEG1000-Mal
Key Properties
- A heterobifunctional PEGylated lipid consisting of a hydrophobic DMG (dimyristoyl glycerol) anchor, a hydrophilic PEG 1000 spacer, and a reactive maleimide (Mal) end group.
- Amphiphilic and neutral at physiological pH, enabling stable insertion into lipid bilayers of LNPs and liposomes.
- The maleimide group reacts specifically with thiol groups (-SH) under mild neutral conditions to form stable covalent thioether bonds.
- Provides both PEG-derived stealth effect and conjugation capability for targeted modification.
- Good biocompatibility, low toxicity, and reduced non-specific protein adsorption.
- Soluble in chloroform, methanol, ethanol, and DMSO; moderately dispersible in aqueous buffers.
- Usually a white to off-white waxy solid.
- Storage: −20 °C, desiccated, protected from light and moisture to avoid maleimide hydrolysis.
Applications
- Used as a reactive PEG lipid for targeted functionalization of lipid nanoparticles (LNPs), liposomes, and micelles.
- Enables conjugation with thiol-containing ligands, peptides, antibodies, aptamers, and targeting molecules.
- Applied in mRNA, siRNA, DNA, and protein delivery systems to enhance targeting specificity.
- Improves colloidal stability and prolongs in vivo circulation time of nanocarriers.
- Used in the development of targeted drug delivery systems, theranostic platforms, and vaccine delivery vehicles.
- Serves as a versatile building block for surface engineering of lipid-based nanomedicines.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
